FORTE Study Updates: November 2024

November 12 2024

FORTE Coordinator Session – November 13

Thank you for being a part of the NRG-CC005/FORTE Trial! Please join the NRG FORTE team for the next site call, an informal discussion on study progress and conduct. Please join for NRG-CC005 protocol updates.

Register today for this session on Teams: November 13; 3:00 pm ET

Accrual Updates and Milestones (as of November 7, 2024)

Top accruing sites:

Kaiser Permanente – Vallejo – 1155 accrued

UPMC-Presbyterian Hospital – 259 accrued

Regions Hospital – 106 accrued

Most recent randomizations:

Kaiser Permanente-Vallejo – November 6, 2024

Kaiser Permanente-Riverside – November 6, 2024

Rocky Mountain Regional VA Medical Center – November 6, 2024

Laura and Isaac Perlmutter Cancer Center at NYU Langone – November 6, 2024

UPMC-Presbyterian Hospital – November 6, 2024

Ralph H Johnson VA Medical Center – November 6, 2024

Recent Trial-Wide Monthly Accrual:

August 2024 – 118 participants

September 2024 – 130 participants

October 2024 – 133 participants

Find both CIRB-approved and protocol-related documents on CTSU under NRG-CC005.

FORTE Resource Portal

Bookmark this website, that organizes materials found on CTSU: https://www.nrgoncology.org/Clinical-Trials/NRG-CC005/FORTE-Resource-Portal. You will use the same login information as for CTSU to access this page. Once you gain access, the “FORTE Materials for Research Professionals” section contains many materials to assist you with accruing participants. This website also has contact information for questions you may have while working on NRG-CC005.

Do you have new research team members working on NRG-CC005?

Clinical research professionals can sign up for NRG Weekly Broadcasts to receive FORTE Fridays updates directly to your inbox: https://www.nrgoncology.org/Home/News/Weekly-Broadcasts.

Questions from Site Research Staff

If research staff have questions about a patient's eligibility or study logistics for the NRG-CC005/FORTE Study, contact the Clinical Coordinating Department (CCD) at: FORTE@nrgoncology.org or 1-800-477-7227.

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.